More about

Resistant Hypertension

News
October 04, 2021
1 min read
Save

Top in cardiology: COVID-19 mortality in patients with HF, cardiac rehab program

Top in cardiology: COVID-19 mortality in patients with HF, cardiac rehab program

New data showed that in-hospital mortality among patients with COVID-19 was nearly twice as high in those with a history of heart failure. A report on the data was the top story in cardiology last week.

News
September 27, 2021
3 min read
Save

Structured lifestyle program for resistant hypertension improves BP, multiple biomarkers

Structured lifestyle program for resistant hypertension improves BP, multiple biomarkers

A 4-month cardiac rehab program for treatment-resistant hypertension focused on diet, exercise and weight loss conferred greater improvement in both in-office and 24-hour ambulatory BP compared with a single educational session.

News
May 17, 2021
2 min read
Save

Ultrasound renal denervation lowers BP in medication-resistant hypertension

Ultrasound renal denervation lowers BP in medication-resistant hypertension

Ultrasound renal denervation for patients with triple-therapy resistant hypertension successfully lowered 24-hour ambulatory BP compared with those who underwent a sham procedure, a speaker reported.

News
June 08, 2020
3 min read
Save

Renal denervation reduces BP in high-risk comorbid conditions

Renal denervation reduces BP in high-risk comorbid conditions

Results from the Global SYMPLICITY Registry found that renal denervation conferred consistent BP reduction in patients with high-risk comorbidities regardless of their atherosclerotic CVD risk score.

News
March 19, 2020
5 min read
Save

Inertia, adherence among critical topics in hypertension

Inertia, adherence among critical topics in hypertension

The problem of hypertension is a multifaceted one. Many factors contribute to the increasing global burden of hypertension. Cardiology Today asked some of the nation’s leading experts on hypertension to glean their thoughts on the most critical issues facing patients and clinicians in that area.

News
September 28, 2019
2 min read
Save

Cardiac neuromodulation therapy drives reduction in BP

Cardiac neuromodulation therapy drives reduction in BP

SAN FRANCISCO — Cardiac neuromodulation therapy resulted in significant reductions in systolic BP at 6 months in patients with persistent hypertension and an indication for a pacemaker, according to data from the MODERATO II study presented at TCT 2019.

News
September 16, 2019
3 min read
Save

AMBER: Patiromer enables persistent spironolactone treatment in patients with hypertension, CKD

AMBER: Patiromer enables persistent spironolactone treatment in patients with hypertension, CKD

PHILADELPHIA — Concomitant use of the potassium binder patiromer enabled more patients with resistant hypertension and advanced chronic kidney disease to continue treatment with spironolactone, with less hyperkalemia, according to new data from the AMBER trial presented at the Heart Failure Society of America Scientific Meeting.

View more